EMX Royalty Co. (CVE:EMX – Free Report) – Equities research analysts at National Bank Financial issued their Q3 2024 EPS estimates for shares of EMX Royalty in a research note issued on Tuesday, October 22nd. National Bank Financial analyst S. Nagle anticipates that the company will earn ($0.01) per share for the quarter. National Bank Financial has a “Strong-Buy” rating on the stock. The consensus estimate for EMX Royalty’s current full-year earnings is $0.01 per share.
EMX Royalty (CVE:EMX – Get Free Report) last released its earnings results on Monday, August 12th. The company reported C($0.05) EPS for the quarter. The company had revenue of C$8.22 million for the quarter. EMX Royalty had a negative return on equity of 2.11% and a negative net margin of 7.44%.
EMX Royalty Stock Down 1.1 %
Insider Buying and Selling at EMX Royalty
In related news, Senior Officer Christina Cepeliauskas sold 20,000 shares of the business’s stock in a transaction on Wednesday, October 16th. The shares were sold at an average price of C$2.57, for a total transaction of C$51,424.00. In other news, Senior Officer Christina Cepeliauskas sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of C$2.57, for a total transaction of C$51,424.00. Also, Director David M. Cole bought 200,000 shares of the company’s stock in a transaction that occurred on Thursday, October 3rd. The stock was bought at an average cost of C$2.05 per share, for a total transaction of C$410,000.00. Insiders own 18.66% of the company’s stock.
EMX Royalty Company Profile
EMX Royalty Corporation, together with its subsidiaries, explores for and generates royalties from metals and minerals properties. It explores gold, silver, platinum, palladium, copper, lead, zinc, manganese, nickel, cobalt, molybdenum, and iron deposits, as well as battery, precious, and base metals.
Read More
- Five stocks we like better than EMX Royalty
- 3 Best Fintech Stocks for a Portfolio Boost
- Texas Roadhouse Stock Steering for New Highs This Year
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Insider Buying Explained: What Investors Need to Know
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for EMX Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EMX Royalty and related companies with MarketBeat.com's FREE daily email newsletter.